Anemia is the most common complication of chronic kidney disease (CKD), associated with heart failure and left ventricular dysfunction in addition to a reduction in exercise capacity and quality of life. Although Erythropoiesis Stimulating Agents (ESA) and iron therapies have led to the improvement in patients suffering from anemia of CKD, new therapies are under …
Continue reading “The Future of Renal Anemia Management: Opportunities & Challenges”